D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$655M |
| 2 |
NVIDIA
NVDA
|
+$579M |
| 3 |
Amazon
AMZN
|
+$425M |
| 4 |
ConocoPhillips
COP
|
+$423M |
| 5 |
Johnson & Johnson
JNJ
|
+$380M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$868M |
| 2 |
Meta Platforms (Facebook)
META
|
+$554M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Pfizer
PFE
|
+$316M |
Sector Composition
| 1 | Technology | 19.2% |
| 2 | Consumer Discretionary | 16.83% |
| 3 | Healthcare | 16.01% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
IAC Inc
IAC
$2.88B
| $28.2M | 0.04% |
726,547
-188,078
| -21% | -$7.31M |
|
452
LivaNova
LIVN
$3.09B
| $28.2M | 0.04% |
392,149
+369,885
| +1,661% | +$26.6M |
|
453
Magna International
MGA
$12.9B
| $28.1M | 0.04% |
565,722
-673,127
| -54% | -$33.5M |
|
454
First Hawaiian
FHB
$3.19B
| $28.1M | 0.04% |
1,086,055
+216,642
| +25% | +$5.6M |
|
455
Canadian National Railway
CNI
$57.7B
| $28.1M | 0.04% |
303,055
+233,038
| +333% | +$21.6M |
|
456
Huntsman Corp
HUN
$1.88B
| $27.7M | 0.03% |
1,356,202
+124,898
| +10% | +$2.55M |
|
457
OraSure Technologies
OSUR
$238M
| $27.6M | 0.03% |
2,971,866
+1,193,709
| +67% | +$11.1M |
|
458
Pilgrim's Pride
PPC
$10.3B
| $27.5M | 0.03% |
1,081,831
+307,281
| +40% | +$7.8M |
|
459
Knowles
KN
$1.85B
| $27.4M | 0.03% |
1,497,769
+15,652
| +1% | +$287K |
|
460
Leidos
LDOS
$23.1B
| $27.3M | 0.03% |
342,323
+95,140
| +38% | +$7.6M |
|
461
Hexcel
HXL
$4.93B
| $27.2M | 0.03% |
336,760
+25,530
| +8% | +$2.06M |
|
462
Sally Beauty Holdings
SBH
$1.45B
| $27.1M | 0.03% |
2,034,872
+87,175
| +4% | +$1.16M |
|
463
Cimpress
CMPR
$1.44B
| $27.1M | 0.03% |
297,962
+127,002
| +74% | +$11.5M |
|
464
Copel
ELP
$6.84B
| $26.9M | 0.03% |
5,295,418
+369,318
| +7% | +$1.88M |
|
465
Neurocrine Biosciences
NBIX
$14B
| $26.8M | 0.03% |
317,651
+158,367
| +99% | +$13.4M |
|
466
Amicus Therapeutics
FOLD
$2.45B
| $26.8M | 0.03% |
2,147,403
+1,146,777
| +115% | +$14.3M |
|
467
NCR Voyix
VYX
$1.73B
| $26.7M | 0.03% |
1,400,317
-186,560
| -12% | -$3.56M |
|
|
AIV
468
Aimco
AIV
$1.07B
| $26.7M | 0.03% |
4,001,487
+2,418,159
| +153% | +$16.1M |
|
469
MRC Global
MRC
$1.24B
| $26.6M | 0.03% |
1,553,748
-596,153
| -28% | -$10.2M |
|
470
Teva Pharmaceuticals
TEVA
$22.4B
| $26.6M | 0.03% |
2,877,537
+2,671,960
| +1,300% | +$24.7M |
|
471
Williams-Sonoma
WSM
$24.7B
| $26.6M | 0.03% |
817,034
-15,380
| -2% | -$500K |
|
|
TVTY
472
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $26.5M | 0.03% |
1,611,396
-784,750
| -33% | -$12.9M |
|
473
Planet Fitness
PLNT
$8.52B
| $26.4M | 0.03% |
364,325
-49,736
| -12% | -$3.6M |
|
474
Workiva
WK
$4.24B
| $26.3M | 0.03% |
453,069
+154,746
| +52% | +$8.99M |
|
475
Trinity Industries
TRN
$2.28B
| $26.3M | 0.03% |
1,267,304
+284,942
| +29% | +$5.91M |
|